Cyclin-dependent kinases as potential targets to improve stroke outcome

Pharmacology and Therapeutics

Volumn 93, Issue 2-3, 2002, Pages 135-143

  O'Hare, Michael ^a   Wang, Fuhu ^a   Park, David S ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Apoptosis; Cyclin dependent kinases; Excitotoxic; Ischemia; Neuronal death; Stroke

Indexed keywords

FLAVOPIRIDOL; CYCLIN DEPENDENT KINASE;

CELL CYCLE; CONFERENCE PAPER; ISCHEMIC HEART DISEASE; NERVE CELL DEGENERATION; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; STROKE; ANIMAL; APOPTOSIS; CEREBROVASCULAR ACCIDENT; DRUG ANTAGONISM; HUMAN; METABOLISM; PHYSIOLOGY; REVIEW;

ANIMAL; APOPTOSIS; CEREBROVASCULAR ACCIDENT; CYCLIN-DEPENDENT KINASES; HUMAN; SUPPORT, NON-U.S. GOV'T; ANIMALS; HUMANS;

EID: 0035990906     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7258(02)00183-3     Document Type: Conference Paper

References (101)

1. Death receptors: Signaling and modulation
2. Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility
3. Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer's disease brain
4. The E2F transcription factor is a cellular target for the RB protein
5. Glutamate neurotoxicity and diseases of the nervous system
6. Requirement for a functional Rb-1 gene in murine development
7. Mitotic signaling by beta-amyloid causes neuronal death
8. Attenuation of p53 expression protects against focal ischemic damage in transgenic mice
9. A synthetic inhibitor of p53 protects neurons against death induced by ischemic and excitotoxic insults, and amyloid beta-peptide
10. Nitric oxide in neurodegeneration
11. Pathobiology of ischaemic stroke: An integrated view
12. The regulation of E2F by pRB-family proteins
13. Role of the Jun kinase pathway in the regulation of c-Jun expression and apoptosis in sympathetic neurons
14. Regulation of G(1) cyclin-dependent kinases in the mammalian cell cycle
15. Caspase pathways, neuronal apoptosis, and CNS injury
16. Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia
17. Neuronal nitric oxide synthase activation and peroxynitrite formation in ischemic stroke linked to neural damage
18. Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase
19. Attenuation of delayed neuronal death after mild focal ischemia in mice by inhibition of the caspase family
20. Altered gene expression in neurons during programmed cell death: Identification of c-jun as necessary for neuronal apoptosis
21. Disrupted cerebellar cortical development and progressive degeneration of Purkinje cells in SV40 T antigen transgenic mice
22. In vivo viability of postmitotic Purkinje neurons requires pRb family member function
23. Unscheduled re-entry into the cell cycle induced by NGF precedes cell death in nascent retinal neurones
24. Analysis of cell cycle-related gene expression in postmitotic neurons: Selective induction of ccyclin D1 during programmed cell death
25. Induction of cyclin B and H1 kinase activity in apoptotic PC12 cells
26. Cisplatin-induced apoptosis in rat dorsal root ganglion neurons is associated with attempted entry into the cell cycle
27. Involvement of cell cycle elements, cyclin-dependent kinases, pRb, and E2F×DP, in B-amyloid-induced neuronal death
28. E2F1 mediates death of B-amyloid-treated cortical neurons in a manner independent of p53 and dependent on Bax and caspase 3
29. Programmed cell death in cerebral ischemia
30. Mitochondria and apoptosis
31. C-Jun and cyclin D1 proteins as mediators of neuronal death after a focal ischaemic insult
32. Attenuation of transient focal cerebral ischemic injury in transgenic mice expressing a mutant ICE inhibitory protein
33. Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage
34. Phosphorylation of retinoblastoma protein in rat brain after transient middle cerebral artery occlusion
35. Programmed cell death in the developing nervous system
36. Cortical development: Cdk5 gets into sticky situations
37. The transcription factor E2F1 modulates apoptosis of neurons
38. Bright and dark sides of nitric oxide in ischemic brain injury
39. Cerebral ischemia and inflammation
40. Effects of an Rb mutation in the mouse
41. Contribution of p53-dependent caspase activation to neuronal cell death declines with neuronal maturation
42. Mild cerebral ischemia induces loss of cyclin-dependent kinase inhibitors and activation of cell cycle machinery before delayed neuronal cell death
43. Involvement of caspase 3 in apoptotic death of cortical neurons evoked by DNA damage
44. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics
45. Cyclin D1 is an essential mediator of apoptotic neuronal cell death
46. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis
47. Neurotoxicity induces cleavage of p35 to p25 by calpain
48. Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: A randomised controlled trial. GAIN International Investigators
49. Free radical pathways in CNS injury
50. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis
51. P53-Immunoreactive protein and p53 mRna expression after transient middle cerebral artery occlusion in rats
52. Apoptosis and protein expression after focal cerebral ischemia in rat
53. Increased expression of cyclin D1 in the adult rat brain following kainic acid treatment
54. Neuroprotection in acute ischaemic stroke. Current status and future potential
55. Apoptosis after experimental stroke: Fact or fashion?
56. Cerebral ischemia produces laddered DNA fragments distinct from cardiac ischemia and archetypal apoptosis
57. Decreased brain infarct following focal ischemia in mice lacking the transcription factor E2F1
58. Nerve growth factor-dependent activation of NF-kappaB contributes to survival of sympathetic neurons
59. Apoptosis, oncosis, and necrosis. An overview of cell death
60. NF-kappaB in neuronal plasticity and neurodegenerative disorders
61. Hippocampal Myc and p53 expression following transient global ischemia
62. Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease
63. Principles of CDK regulation
64. The role of p53 in neuronal cell death
65. Apoptosis by death factor
66. Neuronal cyclin expression in the hippocampus in temporal lobe epilepsy
67. Cell cycle markers in the hippocampus in Alzheimer's disease
68. Arsenite-induced apoptosis in cortical neurons is mediated by c-Jun N-terminal protein kinase 3 and p38 mitogen-activated protein kinase
69. Canadian guidelines for intravenous thrombolytic treatment in acute stroke. A consensus statement of the Canadian Stroke Consortium
70. Induction and modulation of cerebellar granule neuron death by E2F-1
71. Cell death during development of the nervous system
72. Cyclin dependent kinases as a therapeutic target for stroke
73. Role of cell cycle regulatory proteins in cerebellar granule neuron apoptosis
74. Cyclin dependent kinase inhibitors and dominant negative cyclin dependent kinase 4 and 6 promote survival of NGF-deprived sympathetic neurons
75. Cyclin-dependent kinases participate in death of neurons evoked by DNA-damaging agents
76. Involvement of retinoblastoma family members and E2F/DP complexes in the death of neurons evoked by DNA damage
77. Cell cycle regulators in neuronal death evoked by excitotoxic stress: Implications for neurodegeneration and its treatment
78. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration
79. Cyclins and cyclin-dependent kinases: Take your partners
80. Cyclins and their associated cyclin-dependent kinases in the human cell cycle
81. Cyclins and cyclin-dependent kinases: A biochemical view
82. The cyclin-dependent kinase inhibitor p21 (WAF1) is required for survival of differentiating neuroblastoma cells
83. Temporal profile of neuronal damage in a model of transient forebrain ischemia
84. Caspases as treatment targets in stroke and neurodegenerative diseases
85. CDK inhibitors: Positive and negative regulators of G1-phase progression
86. Ki-67 immunoreactivity in Alzheimer's disease and other neurodegenerative disorders
87. Death by design: Mechanism and control of apoptosis
88. Caspase-dependent and -independent death of camptothecin-treated embryonic cortical neurons
89. Triggering and execution of neuronal death in brain ischaemia: Two phases of glutamate release by different mechanisms
90. Phosphorylation of c-Jun NH(2)-terminal kinase and p38 mitogen-activated protein kinase after transient forebrain ischemia in mice
91. Calpain-mediated degradation of p35 to p25 in postmortem human and rat brains
92. Caspases: Enemies within
93. Increased cyclin D1 in vulnerable neurons in the hippocampus after ischaemia and epilepsy: A modulator of in vivo programmed cell death?
94. Mutation of E2f-1 suppresses apoptosis and inappropriate S phase entry and extends survival of Rb-deficient mouse embryos
95. Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain
96. Inhibition of cyclin-dependent kinases improves CA1 neuronal survival and behavioral performance after global ischemia in the rat
97. Activation of mitogen-activated protein kinases after permanent cerebral artery occlusion in mouse brain
98. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis
99. Implication of cysteine proteases calpain, cathepsin and caspase in ischemic neuronal death of primates
100. DNA replication precedes neuronal cell death in Alzheimer's disease
101. E2F3 contributes both to the inappropriate proliferation and to the apoptosis arising in Rb mutant embryos